Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.
Rona Therapeutics is a RNA therapeutics platform enabling discovery, development of modular and programmable RNA medicines.
Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.
Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.
Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.
Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.
ImmuneOnco is a tumor immunotherapy product developer engaged in the development and research of tumor immunotherapy products.
Bioyond Tech utilizes robotics and artificial intelligence technology to provide modular products and automation solutions.
Genesis Medtech is a medical device company.
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.
Singlera is a medical firm that is working to overcome the delay in early diagnosis of cancer through screening and auxiliary.
Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.
Healingovation is a med-tech company that specializes in the development of surgical robots, intelligent diagnosis and treatment equipment.
Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.
Targeting One is an in-vitro diagnostic product developer.
Our purpose is to make every pregnancy around the world safer.
Synnovation Therapeutics is a precision oncology company that develops therapeutics that aims to help people with cancer.
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.
Qihan Biotech is a gene-editing organ transplantation technology developer.
Eluminex Biosciences is dedicated to the research and commercialization of novel therapies to address unmet medical needs.
Langlai Technology is a clinical-stage innovative drug research and development company.
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Yinghe Brain Science is a neuromodulation platform developer
MediTrust Health is a Leading Healthcare Platform in China
Lilly Asia Ventures has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Lilly Asia Ventures's top investment sectors include Biotechnology, Health Care, Medical, Pharmaceutical, Therapeutics. The firm invests across 17 different industry categories.
Among tracked funding rounds, Verdiva Bio received $411.0M in a Series A round. Lilly Asia Ventures's total known invested capital is $7.8B.
Lilly Asia Ventures's average investment size is $88.3M across its portfolio of 102 companies.
Recent Lilly Asia Ventures portfolio additions include Novlead Biotech, Rona Therapeutics, Inhibrx, Verdiva Bio, Timberlyne Therapeutics. These companies were founded in 2020 or later.